Cited by 299Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.

New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats

Open access

Abstract

We describe a touchscreen method that satisfies a proposed 'wish-list' of desirables for a cognitive testing method for assessing rodent models of schizophrenia. A number of tests relevant to schizophrenia research are described which are currently being developed and validated using this method. These tests can be used to study reward learning, memory, perceptual discrimination, object-place associative learning, attention, impulsivity, compulsivity, extinction, simple Pavlovian conditioning, and other constructs. The tests can be deployed using a 'flexible battery' approach to establish a cognitive profile for a particular mouse or rat model. We have found these tests to be capable of detecting not just impairments in function, but enhancements as well, which is essential for testing putative cognitive therapies. New tests are being continuously developed, many of which may prove particularly valuable for schizophrenia research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2011.04.011

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–208 of 208

Flagged first, then by citations

Research works printed but not linked: 2

  1. Leeson, 2009, Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome, Biol. Psychiatry, 66, 586, 10.1016/j.biopsych.2009.05.016 · DOI · Paper page
  2. Nuechterlein, 2008, The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity, Am. J. Psychiatry, 165, 203, 10.1176/appi.ajp.2007.07010042 · DOI · Paper page

Cited by

Sorted by citations

See all 299

Metadata

Authors
Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C., McAllister, K. A. L., Nithianantharajah, J., Oomen, C. A., & Saksida, L. M.
Affiliations
  • University of Cambridge (GB)
  • National Institutes of Health (US)
Corresponding author
Bussey, T.J.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2012-03
Volume
62
Issue
3
Pages
1191-1203
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2099186316
Cited by
299
References
208
Citations by year
2026: 6 · 2025: 13 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 55 · 2020: 27 · 2019: 19 · 2018: 22 · 2017: 29 · 2016: 18 · 2015: 28 · 2014: 13 · 2013: 16 · 2012: 17
FWCI
11.60
Type
journal article
Language
en
Open access
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Commonwealth Trust, Janssen Pharmaceutica
  • National Institute on Alcohol Abuse and Alcoholism Intramural Research Program
  • Innovative Medicines Initiative Joint Undertaking (IMI) (115008)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
schizophrenia, cognitive assessment, rodent models, cognitive enhancement, reward learning, memory, perceptual discrimination, attention, impulsivity, compulsivity, extinction, classical conditioning, flexible batteries, cognitive profile, cognitive therapy
MeSH terms
Animals, Cognition Disorders, Computers, Discrimination, Psychological, Disease Models, Animal, Neuropsychological Tests, Photic Stimulation, Psychomotor Performance, Schizophrenia, Schizophrenic Psychology, Touch, Mice, Rats, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review